Search research articles
Contact Us
Filters
Showing results (231-240 of 304) with videos related to
Page
of 31
Sort By:
Annals of Neurology
|
July 11, 2025
Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior Disorder
Daniel Weintraub, Anuprita R Nair, Ryan Kurth, et al.
Annals of Clinical and Translational Neurology
|
December 20, 2018
The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort
Kenneth Marek, Sohini Chowdhury, Andrew Siderowf, et al.
Microbiome
|
October 7, 2025
Integrated multi-omics highlights alterations of gut microbiome functions in prodromal and idiopathic Parkinson's disease
Rémy Villette, Júlia Ortís Sunyer, Polina V Novikova, et al.
Neurology
|
September 27, 2013
Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study
Hongliu Ding, Kaltra Dhima, Kaitlin C Lockhart, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 20, 2020
Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study
Tanya Simuni, Michael C Brumm, Liz Uribe, et al.
Brain : a Journal of Neurology
|
September 30, 2021
Blood DNA methylation provides an accurate biomarker of KMT2B-related dystonia and predicts onset
Nazanin Mirza-Schreiber, Michael Zech, Rory Wilson, et al.
NPJ Parkinson'S Disease
|
June 26, 2026
A comprehensive assessment of lifecourse and mortality of Parkinson's disease in the German National Cohort
Klaus Berger, André Karch, Christina M Lill, et al.
The Lancet. Neurology
|
July 7, 2019
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial
Johannes Levin, Sylvia Maaß, Madeleine Schuberth, et al.
NPJ Parkinson'S Disease
|
February 11, 2023
A proteogenomic view of Parkinson's disease causality and heterogeneity
Sergio Kaiser, Luqing Zhang, Brit Mollenhauer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 17, 2020
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression
Brit Mollenhauer, Mohammed Dakna, Niels Kruse, et al.
Page
of 31
Search research articles
Search
Showing results (231-240 of 304) with videos related to
Sort By:
Page
of 31
Annals of Neurology
|
July 11, 2025
Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior Disorder
Daniel Weintraub, Anuprita R Nair, Ryan Kurth, et al.
Annals of Clinical and Translational Neurology
|
December 20, 2018
The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort
Kenneth Marek, Sohini Chowdhury, Andrew Siderowf, et al.
Microbiome
|
October 7, 2025
Integrated multi-omics highlights alterations of gut microbiome functions in prodromal and idiopathic Parkinson's disease
Rémy Villette, Júlia Ortís Sunyer, Polina V Novikova, et al.
Neurology
|
September 27, 2013
Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study
Hongliu Ding, Kaltra Dhima, Kaitlin C Lockhart, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 20, 2020
Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study
Tanya Simuni, Michael C Brumm, Liz Uribe, et al.
Brain : a Journal of Neurology
|
September 30, 2021
Blood DNA methylation provides an accurate biomarker of KMT2B-related dystonia and predicts onset
Nazanin Mirza-Schreiber, Michael Zech, Rory Wilson, et al.
NPJ Parkinson'S Disease
|
June 26, 2026
A comprehensive assessment of lifecourse and mortality of Parkinson's disease in the German National Cohort
Klaus Berger, André Karch, Christina M Lill, et al.
The Lancet. Neurology
|
July 7, 2019
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial
Johannes Levin, Sylvia Maaß, Madeleine Schuberth, et al.
NPJ Parkinson'S Disease
|
February 11, 2023
A proteogenomic view of Parkinson's disease causality and heterogeneity
Sergio Kaiser, Luqing Zhang, Brit Mollenhauer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 17, 2020
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression
Brit Mollenhauer, Mohammed Dakna, Niels Kruse, et al.
Page
of 31